Insider Transactions in Q1 2025 at Encompass Health Corp (EHC)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2025
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,079
-1.74%
|
$107,900
$100.63 P/Share
|
|
Feb 25
2025
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
509
-0.63%
|
$50,900
$100.63 P/Share
|
|
Feb 25
2025
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
506
-2.96%
|
$50,600
$100.63 P/Share
|
|
Feb 25
2025
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
384
-0.38%
|
$38,400
$100.63 P/Share
|
|
Feb 25
2025
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,896
-0.54%
|
$289,600
$100.63 P/Share
|
|
Feb 25
2025
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
410
-0.58%
|
$41,000
$100.63 P/Share
|
|
Feb 24
2025
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
927
-1.47%
|
$89,919
$97.53 P/Share
|
|
Feb 24
2025
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
437
-0.54%
|
$42,389
$97.53 P/Share
|
|
Feb 24
2025
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
435
-2.48%
|
$42,195
$97.53 P/Share
|
|
Feb 24
2025
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
374
-0.37%
|
$36,278
$97.53 P/Share
|
|
Feb 24
2025
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,488
-0.47%
|
$241,336
$97.53 P/Share
|
|
Feb 24
2025
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
401
-0.57%
|
$38,897
$97.53 P/Share
|
|
Feb 20
2025
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,557
+6.73%
|
-
|
|
Feb 20
2025
|
Elissa Joy Charbonneau Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,939
+9.95%
|
-
|
|
Feb 20
2025
|
John Patrick Darby EVP, Gen Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
2,216
+2.66%
|
-
|
|
Feb 20
2025
|
Edmund Fay Sr. Vice Pres. and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
1,404
+1.37%
|
-
|
|
Feb 20
2025
|
Mark J Tarr President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,152
+2.22%
|
-
|
|
Feb 20
2025
|
Andrew L Price Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,538
+2.13%
|
-
|
|
Feb 13
2025
|
Andrew L Price Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,042
-6.79%
|
$494,116
$98.29 P/Share
|
|
Jan 16
2025
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
375
+2.88%
|
$35,250
$94.38 P/Share
|
|
Jan 16
2025
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
292
+5.84%
|
$27,448
$94.4 P/Share
|
|
Jan 15
2025
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
36
+0.18%
|
-
|
|
Jan 15
2025
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.18%
|
-
|
|
Jan 15
2025
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.19%
|
-
|
|
Jan 15
2025
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.17%
|
-
|
|
Jan 15
2025
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.13%
|
-
|
|
Jan 15
2025
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
25
+0.15%
|
-
|
|
Jan 15
2025
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
83
+0.18%
|
-
|
|
Jan 15
2025
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
83
+0.18%
|
-
|
|
Jan 15
2025
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
6
+0.14%
|
-
|
|
Jan 01
2025
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,438
-17.52%
|
$1,144,296
$92.35 P/Share
|
|
Jan 01
2025
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,991
-16.09%
|
$275,172
$92.35 P/Share
|
|
Jan 01
2025
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,291
-2.24%
|
$210,772
$92.35 P/Share
|
|
Jan 01
2025
|
Mark J Tarr President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,609
-5.7%
|
$2,908,028
$92.35 P/Share
|
|
Jan 01
2025
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,917
-6.98%
|
$544,364
$92.35 P/Share
|
|
Jan 01
2025
|
Andrew L Price Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,446
-3.19%
|
$225,032
$92.35 P/Share
|